(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Energy and Utilities
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > In Vitro Diagnostics >  Tumor Markers
 
 Tumor Markers Market Research Reports
Title

To order sections of the reports, contact Client Services.

Price
« Previous  1  2  3  4  5  Next »
Tumor Markers, and Strategic Profiles of Leading Reagent and Instrument Suppliers

This 286-page report presents comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.



 

$3850.00
       
Tumor Marker Testing Technologies and Strategic Profiles of Leading Suppliers

This 185-page report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for tumor markers technologies. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.



 

$3850.00
       
Analysis of the World Tumor Markers Testing Market
Sales Forecasts by Country and Strategic Profiles of Leading Suppliers


This report provides estimates of the number of laboratories performing tumor marker assays, as well as test volume and sales forecasts by country.

The report also presents strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.



 

$3500.00
       
Analysis of Emerging Tumor Markers
and Strategic Profiles of Leading Suppliers


This 286-page report presents comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.



 

$3500.00
       
Analysis of Tumor Marker Testing Instrumentation
And Strategic Profiles of Leading Suppliers


This 119-page report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for tumor marker testing.



 

$3500.00
       
Analysis of Tumor Markers Technologies
And Strategic Profiles of Leading Suppliers


This 185-page report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for tumor markers technologies. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.



 

$3500.00
       
Emerging Strategies for the Global Tumor Marker Testing Market: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

This report provides estimates of the number of laboratories performing tumor marker assays, as well as test volume and sales forecasts by country.

The report also presents strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.



 

$3500.00
       
Tumor Markers: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

This report provides estimates of the number of laboratories performing tumor marker assays, as well as test volume and sales forecasts by country.

The report also presents strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.



 

$3500.00
       
Emerging Tumor Markers and Companies Developing Innovative Technologies and Products

Highlights

  • Comprehensive 260-page market and technological assessment.
  • Medical rationale and diagnostic prospects for major categories of both circulating and cellular tests, such as :

  • - Biochemical Markers
    - Oncogenes
    - Growth Factors
    - Hormones
    - Colony Stimulating Factors
    - Lymphokines
    - Immunohistochemical Stains.



 

$2850.00
       
Analysis of the US Hospital Tumor Marker Testing Market

This new report from Venture Planning Group contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital tumor market testing market, including:



 

$2800.00
       
Leading Tumor Marker Diagnostics Market Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants

This 80-page report presents strategic analyses of major current and emerging suppliers of tumor markers.

For each company the report presents:

  • Sales
  • Market shares
  • Product portfolios
  • Distribution tactics
  • Technological know-how
  • New products in R&D
  • Collaborative arrangements
  • Business strategies.

Contains 80 pages



 

$2500.00
       
Competitive Intelligence: Leading Tumor Marker Diagnostics Market Players--Strategic Assessments of Major Suppliers and Emerging Market Entrants

This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. The assessments include:
  • Sales
  • Product portfolios
  • Distribution tactics
  • Technological know-how
  • New products in R&D
  • Collaborative arrangements
  • Business strategies.

Contains 80 pages



 

$2500.00
       
CompetitiveWatch Tumor Markers: Strategic Assessments of Major Suppliers

This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents.

The assessments include:

  • Sales
  • Product portfolios
  • Distribution tactics
  • Technological know-how
  • New products in R&D
  • Collaborative arrangements
  • Business strategies.

Contains 80 pages



 

$2500.00
       
Emerging Opportunities in the Tumor Markers Testing Market: Strategic Assessments of Major Suppliers

This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents.�

The assessments include:

  • Sales
  • Product portfolios
  • Distribution tactics
  • Technological know-how
  • New products in R&D
  • Collaborative arrangements
  • Business strategies.

Contains 80 pages



 

$2500.00
       
Australia Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Test Volume and Sales Forecasts, Competitive Strategies, Opportunities

This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....


 

$2500.00
       
Austria Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Test Volume and Sales Forecasts, Competitive Strategies, Opportunities

This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....


 

$2500.00
       
Belgium Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Test Volume and Sales Forecasts, Competitive Strategies, Opportunities

This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....


 

$2500.00
       
Bulgaria Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Test Volume and Sales Forecasts, Competitive Strategies, Opportunities

This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....


 

$2500.00
       
« Previous     1  2  3  4  5   Next »
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X